Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 13, 2015 11:20 PM ET


Company Overview of T2 Biosystems, Inc.

Company Overview

T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States. Its T2 Magnetic Resonance platform enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, and urine. The company offers T2Dx, a bench-top instrument for sepsis, Lyme disease, and other applications; T2Candida panel for identifying pathogens associated with sepsis; and T2MR Platform, a magnetic resonance-based approach that measures how water molecules react in the presence of magnetic fields. It is also developing T2Stat, an integrated instrument that provi...

101 Hartwell Avenue

Lexington, MA 02421

United States

Founded in 2006

110 Employees





Key Executives for T2 Biosystems, Inc.

Chief Executive Officer, President and Director
Age: 55
Total Annual Compensation: $380.4K
Chief Operating Officer
Age: 56
Total Annual Compensation: $89.8K
Chief Medical Officer
Age: 64
Total Annual Compensation: $228.4K
Chief Scientific Officer
Age: 36
Total Annual Compensation: $274.3K
Compensation as of Fiscal Year 2014.

T2 Biosystems, Inc. Key Developments

T2 Biosystems, Inc. Announces Results from Data Analysis of the Company's T2Candida® Panel

T2 Biosystems, Inc. announced that results from a data analysis of the company's T2Candida® Panel for the detection and monitoring of Candida infection and sepsis were published in Future Microbiology. The publication compared aggregated results from T2Candida in the detection of invasive candidiasis and candidemia to blood culture, which included samples acquired from more than 1,900 patients. Out of 55 total cases, T2Candida demonstrated a 96.4% sensitivity (53 cases) compared to 60% (33 cases) with blood culture.

T2 Biosystems, Inc. Presents at Morgan Stanley Global Healthcare Conference - New York, Sep-17-2015 02:55 PM

T2 Biosystems, Inc. Presents at Morgan Stanley Global Healthcare Conference - New York, Sep-17-2015 02:55 PM. Venue: The Grand Hyatt New York, 109 East 42nd Street, New York, New York, United States. Speakers: John P. McDonough, Chief Executive Officer, President and Director.

T2 Biosystems Eyes Acquisitions

T2 Biosystems, Inc. (NasdaqGM:TTOO) is looking for acquisition opportunities. T2 Biosystems, Inc. has filed a Shelf Registration in the amount of $43 million. T2 Biosystems intend to use the net proceeds from the sale of the securities being offered by us for general corporate purposes unless otherwise indicated in the applicable prospectus supplement. General corporate purposes may include acquisition of companies or businesses, repayment and refinancing of debt, working capital, research and development expenditures, clinical trial expenditures, commercial expenditures and capital expenditures. We have not determined the amount of net proceeds to be used specifically for such purposes.

Similar Private Companies By Industry

Company Name Region
IntegraGen, Inc. United States
Human Genome Sciences Inc. United States
Myrmidon Biomaterials Inc. United States
PellePharm, Inc. United States
Immunomatrix, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact T2 Biosystems, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at